Now Is the Perfect Time to Invest in Coronavirus Vaccine Stocks

After all of these months of tracking coronavirus vaccine developers' progress, we're nearing the final stages of the race. As of today, nine programs are in phase 3 studies. And a vaccine may come even before the completion of that stage. U.S. Food and Drug Administration Commissioner Stephen Hahn recently said the agency would consider a possible emergency use authorization before phase 3 trials are over.

If you haven't bought coronavirus vaccine stocks yet, you may be thinking that you missed your opportunity. But that isn't the case. In fact, now is the perfect time to invest. The reasons? Compared to several weeks ago, share prices are more reasonable, and more information is available regarding each company's program. And for the eventual winners, the best is yet to come: They are likely to benefit from near-term and long-term share gains.

Image source: Getty Images.

Continue reading

Source Fool.com